In 1982, the U.S. Food and Drug Administration (FDA) approved Accutane for the treatment of severe, recalcitrant nodular acne ...

Cip-isotretinoin is indicated for the treatment of severe recalcitrant nodular acne. It is expected to be available in the United States in the fourth quarter of 2012 under the brand name Absorica.

Image: Adobe Stock. Approved for the treatment of severe recalcitrant nodular acne in patients aged 12 years and older, micronized isotretinoin 0.4 mg/kg to 0.8 mg/kg diffused in a lipid carrier ...

In September 1982, the US Food and Drug Administration (FDA) approved the drug isotretinoin (Accutane) for use in the treatment of severe recalcitrant nodular acne. Accutane, taken orally over 20 ...

The product is indicated for the management of severe recalcitrant nodular acne in patients 12 years of age and older. Absorica LD is the only isotretinoin formulation to feature Sun Pharma’s ...

Patients with severe acne had significantly greater improvement when topical adapalene/benzoyl peroxide (Epiduo) was added to oral doxycycline, according to results of a randomized clinical trial.

D.A. Dear D.A.: Isotretinoin (Accutane in Canada, several brands in the U.S.) is a powerful treatment for acne, a derivative of vitamin A. It is indicated for severe, recalcitrant nodular acne ...

Dr. Reddy’s has announced the relaunch of Zenatane (isotretinoin capsules) for the treatment of severe recalcitrant nodular acne unresponsive to conventional therapy (eg, systemic antibiotics).

Fortress Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products. The company markets dermatology products, including Emrosi, a ...

The program is designed to reduce the risk of fetal exposure to isotretinoin, or Accutane, a drug used to treat severe recalcitrant nodular acne. Those changes include eliminating the 23-day ...

“Other acne is typically caused by simple blockage of the skin, but nodular acne is more of a mixture of hormones and bacteria that makes it very severe,” says Vladyslava Doktor, DO, a ...